XML 35 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Sub-Total ASHS
Non-controlling Interests in Subsidiaries
Beginning balance at Dec. 31, 2017 $ 29,885 $ 10,711 $ 6,272 $ 6,873 $ 23,856 $ 6,029
Beginning balance (in shares) at Dec. 31, 2017   5,710        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 55 $ 0 55 0 55 0
Stock-based compensation expense (in shares)   0        
Net income 651 $ 0 0 390 390 261
Ending balance at Mar. 31, 2018 30,591 $ 10,711 6,327 7,263 24,301 6,290
Ending balance (in shares) at Mar. 31, 2018   5,710        
Beginning balance at Dec. 31, 2017 29,885 $ 10,711 6,272 6,873 23,856 6,029
Beginning balance (in shares) at Dec. 31, 2017   5,710        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,439          
Ending balance at Sep. 30, 2018 31,023 $ 10,711 6,441 7,718 24,870 6,153
Ending balance (in shares) at Sep. 30, 2018   5,714        
Beginning balance at Mar. 31, 2018 30,591 $ 10,711 6,327 7,263 24,301 6,290
Beginning balance (in shares) at Mar. 31, 2018   5,710        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 57 $ 0 57 0 57 0
Stock-based compensation expense (in shares)   4        
Cash distributions to non-controlling interests (77) $ 0 0 0 0 (77)
Net income 500 0 0 287 287 213
Ending balance at Jun. 30, 2018 31,071 $ 10,711 6,384 7,550 24,645 6,426
Ending balance (in shares) at Jun. 30, 2018   5,714        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 57 $ 0 57 0 57 0
Stock-based compensation expense (in shares)   0        
Cash distributions to non-controlling interests (393) $ 0 0 0 0 (393)
Net income 288 0 0 168 168 120
Ending balance at Sep. 30, 2018 31,023 $ 10,711 6,441 7,718 24,870 6,153
Ending balance (in shares) at Sep. 30, 2018   5,714        
Beginning balance at Dec. 31, 2018 31,048 $ 10,711 6,495 7,896 25,102 5,946
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 55 $ 0 55 0 55 0
Stock-based compensation expense (in shares)   0        
Cash distributions to non-controlling interests (19) $ 0 0 0 0 (19)
Net income 395 0 0 270 270 125
Ending balance at Mar. 31, 2019 31,479 $ 10,711 6,550 8,166 25,427 6,052
Ending balance (in shares) at Mar. 31, 2019   5,714        
Beginning balance at Dec. 31, 2018 31,048 $ 10,711 6,495 7,896 25,102 5,946
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 1,028          
Options exercised (in shares) 16          
Ending balance at Sep. 30, 2019 $ 31,422 10,752 6,665 8,362 25,779 5,643
Beginning balance at Mar. 31, 2019 31,479 10,711 6,550 8,166 25,427 6,052
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 53 $ 0 53 0 53 0
Stock-based compensation expense (in shares)   86        
Cash distributions to non-controlling interests (57) $ 0 0 0 0 (57)
Net income 279 0 0 31 31 248
Ending balance at Jun. 30, 2019 31,754 $ 10,711 6,603 8,197 25,511 6,243
Ending balance (in shares) at Jun. 30, 2019   5,800        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 62 $ 0 62 0 62 0
Stock-based compensation expense (in shares)   0        
Cash distributions to non-controlling interests (789) $ 0 0 0 0 (789)
Net income 354 0 0 165 165 189
Options exercised 41 $ 41 0 0 41 0
Options exercised (in shares)   16        
Ending balance at Sep. 30, 2019 $ 31,422 $ 10,752 $ 6,665 $ 8,362 $ 25,779 $ 5,643